- Dental Silver Diamine Fluoride (SDF), a topical medicament used to arrest dental caries and prevent further decay, is becoming an increasingly essential component of preventive and minimally invasive dentistry in pediatric, geriatric, and special needs populations due to its affordability, ease of application, and proven clinical efficacy
- The growing demand for SDF is primarily fueled by rising awareness of non-invasive caries treatment, increasing prevalence of untreated dental decay, and expanding acceptance of SDF by dental associations and healthcare providers worldwide
- North America dominated the dental silver diamine fluoride (SDF) market with the largest revenue share of 39.5% in 2024, supported by the strong presence of regulatory-approved products, active public health programs, and growing integration of SDF in school-based dental care initiatives, particularly in the U.S., where Medicaid coverage and clinical endorsements have accelerated adoption
- Asia-Pacific is expected to be the fastest growing region in the dental silver diamine fluoride (SDF) market during the forecast period due to expanding access to dental care, rising investments in oral health infrastructure, and increasing public health awareness in emerging economies
- The pediatric segment dominated the dental silver diamine fluoride (SDF) market with a market share of 48% in 2024, driven by its wide use in managing childhood caries without the need for anesthesia or drilling, making it a favorable solution for young and anxious patients
